4.29

1.66% 0.07

After Hours: 4.29

Orasure Technologies Inc (OSUR)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Orasure Technologies Inc stock is traded at $4.29, with a volume of 524.20K. It is up +1.66% in the last 24 hours and up +3.62% over the past month. OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

Previous Close:

$4.22

Open:

$4.2

24h Volume:

524.20K

Relative Volume:

0.88

Market Cap:

$314.68M

Revenue:

$405.47M

Net Income/Loss:

$53.66M

P/E Ratio:

7.3966

EPS:

0.58

Net Cash Flow:

$131.28M

1W Performance:

+0.70%

1M Performance:

+3.62%

6M Performance:

-21.86%

1Y Performance:

-23.80%

1-Day Range:

$4.179

$4.315

1-Week Range:

$4.06

$4.315

52-Week Range:

$3.915

$8.45

Orasure Technologies Inc Stock (OSUR) Company Profile

Name

Orasure Technologies Inc

Sector

Healthcare (1182)

Industry

Medical Instruments & Supplies (58)

Phone

(503) 641-6115

Address

220 E FIRST ST, BETHLEHEM, PA

Employee

638

Twitter

@orasure

Next Earnings Date

2024-11-06

Latest SEC Filings

OSUR's Discussions on Twitter

Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-03-23	Resumed	Evercore ISI	In-line
Sep-22-21	Downgrade	Raymond James	Outperform → Mkt Perform
Aug-21-20	Initiated	Evercore ISI	Outperform
Aug-10-20	Initiated	Citigroup	Buy
Aug-10-20	Initiated	JP Morgan	Neutral
Aug-07-20	Upgrade	Raymond James	Mkt Perform → Outperform
Jun-25-20	Initiated	Lake Street	Buy
Apr-21-20	Resumed	Stephens	Equal-Weight
Oct-23-18	Resumed	Raymond James	Mkt Perform
Jul-16-18	Downgrade	Stephens	Overweight → Equal-Weight
Nov-02-17	Downgrade	Jefferies	Buy → Hold
Feb-09-17	Upgrade	Raymond James	Mkt Perform → Outperform
Jun-13-16	Downgrade	Raymond James	Outperform → Mkt Perform
Nov-05-15	Reiterated	Mizuho	Buy
May-07-15	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jan-23-15	Reiterated	Mizuho	Buy
Jun-12-14	Reiterated	Canaccord Genuity	Buy
Jun-11-14	Reiterated	Mizuho	Buy
Dec-21-12	Initiated	Mizuho	Buy
Aug-08-12	Upgrade	Barrington Research	Mkt Perform → Outperform
Jul-05-12	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-27-12	Initiated	JMP Securities	Mkt Outperform

View All

Orasure Technologies Inc Stock (OSUR) Latest News

02:54 AM

Vanguard Group Inc's Strategic Acquisition in OraSure Technologies Inc - GuruFocus.com

02:54 AM

Nov 04, 2024

OraSure: An NCAV Diamond In The COVID Rough (NASDAQ:OSUR) - Seeking Alpha

Nov 04, 2024

Nov 01, 2024

Allspring Global Investments Holdings LLC Trims Stock Holdings in OraSure Technologies, Inc. (NASDAQ:OSUR) - MarketBeat

Nov 01, 2024

Oct 30, 2024

OraSure Technologies (OSUR) to Release Earnings on Wednesday - MarketBeat

Oct 30, 2024

Oct 29, 2024

Microbiome Diagnostics Market to hit USD 429.2 million by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.

Oct 29, 2024

Oct 24, 2024

OraSure hosts HIV summit for various stakeholders - Drug Discovery & Development

Oct 24, 2024

Oct 23, 2024

Finding top talent is challenging for Lehigh Valley companies - Lehigh Valley Business

Oct 23, 2024

OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th - ForexTV.com

Oct 23, 2024

Oct 15, 2024

Drug Screening Market Worth USD 7.5 Billion In 2022, Growing At A CAGR Of 11.33% As Revealed In New Report - WhaTech

Oct 15, 2024

Oct 13, 2024

Short Interest in OraSure Technologies, Inc. (NASDAQ:OSUR) Decreases By 20.6% - MarketBeat

Oct 13, 2024